Navigation Links
Watson Completes Acquisition of CRINONE® and PROCHIEVE® Product Line and Shares of Columbia Laboratories
Date:7/2/2010

MORRISTOWN, N.J., July 2 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI) today completed the acquisition of the U.S. rights to Columbia Laboratories' CRINONE® and PROCHIEVE® progesterone gel product line and 11,200,000 shares of Columbia common stock.

"We are pleased to add CRINONE® and PROCHIEVE® to our growing number of women's health products. The addition of these products for infertility and secondary amenorrhea marks an important step toward broadening Watson's treatment categories in women's health," said Paul Bisaro, Watson's President and Chief Executive Officer. "These products will quickly become an integral part of our growing brand portfolio and we will aim to substantially grow these products utilizing Watson's Brand sales team. We are also pleased with the progress Columbia has made in their Phase 3 clinical study as we collaborate together in pursuit of a NDA filing for a pre-term birth indication for PROCHIEVE® in 2011. We are confident that our partnership with Columbia will be a strong one and that we will achieve many positive results together."

Under the terms of the agreement, Watson paid Columbia an initial $47 million payment for exclusive progesterone gel product rights in the U.S. and received 11,200,000 million newly issued shares of Columbia common stock. Watson also has the right to designate a member to Columbia's board of directors. Additional contingent payments related to the successful
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Watson Launches Generic Biaxin(R) XL
2. Watson Announces Positive Results From Its Pivotal Study of Oxybutynin Topical Gel for the Treatment of Overactive Bladder
3. Watson Announces Silodosin NDA Accepted for Filing by FDA for the Treatment of Benign Prostatic Hyperplasia
4. Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder
5. Watson Announces United States Availability of RAPAFLO(TM) (silodosin), a Novel New Treatment in Benign Prostatic Hyperplasia (BPH)
6. Watson and Barr Settle Lawsuit Over Oxytrol(R)
7. Watson to Host Conference Call and Webcast to Discuss Fourth Quarter 2009 Earnings and 2010 Outlook
8. Watson Completes Acquisition of Eden Biodesign
9. Watson to Present at Credit Suisse Healthcare Conference
10. Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Deprivation Therapy
11. Watson Files FDA Application for Generic Rozerem(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... experimental drug designed to help regulate the blood,s iron supply ... inflammation, according to results from the first human study ... Blood , the Journal of the American Society ... condition that occurs when red blood cells are in short ... anemia, the body does not get enough oxygen, since there ...
(Date:8/27/2014)... Kewaunee Scientific Corporation (Nasdaq: KEQU ... quarterly cash dividend by 9% to twelve cents per ... with the dividend payable on September 22, 2014 to ... September 8, 2014. About Kewaunee Scientific ... Corporation is a recognized global leader in the design, ...
(Date:8/27/2014)... NINGBO, China , Aug. 27, 2014 /PRNewswire/ ... Co., Ltd, ("Menovo") today announced they had entered into ... primarily targeting the United States ... Menovo will jointly develop products for Amerigen to commercialize ... will be responsible for manufacturing API and finished product ...
Breaking Medicine Technology:Drug Represents First Potential Treatment for Common Anemia 2Drug Represents First Potential Treatment for Common Anemia 3Amerigen Pharmaceuticals Limited and the Ningbo Menovo Pharmaceutical Co., Ltd, today announced they had entered into a collaboration agreement regarding the development of generic pharmaceuticals, primarily targeting the United States market 2
... ORANGE COUNTY, Calif., Nov. 23 Beckman Coulter, Inc. ... and marketer of products that simplify, automate, and innovate ... Coulter,s vice president of strategy, will present at the ... at 12:00 p.m. (ET). , (Logo: http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGO ) ...
... , NEW ... market research report is available in its catalogue. , ... 2015 , http://www.reportlinker.com/p0164603/The-Future-of-the-Diagnostic-Imaging-Market-to-2015.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire ... of the Diagnostic Imaging Market to 2015 , ...
Cached Medicine Technology:Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 2Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 3Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 4Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 5Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 6Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 7Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 8Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 9Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 10Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 11Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 12
(Date:8/27/2014)... 2014 New Jersey’s own Morgan Hoffmann ... County Club during The Barclays – and thanks to ... the tournament’s four rounds, stepped his way into raising ... Blue Shield of New Jersey (Horizon BCBNSNJ) Walking Challenge. ... native playing before family and friends at the Paramus ...
(Date:8/27/2014)... HealthDay Reporter WEDNESDAY, Aug. 27, ... a dark alley will likely never want to return there, ... But neuroscientists working with mice say they,ve discovered the ... and negative emotions. And in rodent tests, they,ve manipulated brain ... In essence, they made once-reluctant mice want to return to ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 Ticket Down ... Chile tickets at Levi’s Stadium in Santa Clara. ... Santa Clara, California just opened in July and will host ... Mexico takes on Chile. These are two of the best ... 2014 World Cup and will look to continue their successes ...
(Date:8/27/2014)... key role in inflaming blood vessels and hardening arteries, ... UCLA demonstrates that they may also contribute to pulmonary ... blood vessels in the lungs. , Using a rodent ... of the main protein in high-density lipoprotein (HDL), the ... oxidized lipids in pulmonary hypertension. They also found that ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 ANS ... System, a ground breaking anti-cancer therapy for the treatment ... certified to prescribe this new medical therapy and will ... patients starting immediately. , NovoTTF™ Therapy is a portable, ... patients 22 years of age and older. It is ...
Breaking Medicine News(10 mins):Health News:Morgan Hoffmann, PGA TOUR Pro & Wyckoff Native, golfs and walks his way to top 10 finish at The Barclays while raising additional $7,500 for charity 2Health News:Scientists 'Rewrite' Bad Memories in Mice 2Health News:Scientists 'Rewrite' Bad Memories in Mice 3Health News:Mexico vs. Chile Tickets at Levi’s Stadium: Ticket Down Cuts Ticket Prices for Inaugural Soccer Match between Chile and Mexico in Santa Clara 2Health News:Mexico vs. Chile Tickets at Levi’s Stadium: Ticket Down Cuts Ticket Prices for Inaugural Soccer Match between Chile and Mexico in Santa Clara 3Health News:Protein in 'good cholesterol' may be a key to treating pulmonary hypertension 2Health News:Atlantic NeuroSurgical Specialists (ANS) Announces Availability of New Therapy for Brain Cancer 2Health News:Atlantic NeuroSurgical Specialists (ANS) Announces Availability of New Therapy for Brain Cancer 3
... BALTIMORE, Nov. 19 Care Improvement Plus, one of ... today,that it has received top scores from the Centers ... its structure and process measures. The,measures are the first ... SNPs in providing high quality care and improving health,outcomes ...
... , TORONTO, Nov. 19 /PRNewswire-FirstCall/ - ... development and commercialization of cancer therapies, announced today that ... II data from Neuradiab(TM) at the Society for Neuro-Oncology,s ... results from two previously conducted Phase II trials, is ...
... announced today that its “OneMedForum 2009” finance conference ... 13-14, 2009, in San Francisco at the Sir ... annual OneMedForum event is to be a vital ... Toward that end, the two-day OneMedForum event will ...
... innovator asks the regenerative medicine community: "Are Your Cells Free?" Learn more ... CA. , ... Fort Collins, CO (PRWEB) November 19, 2008 -- ... the 2008 North American Tissue Engineering Meeting TERMIS in San ...
... VTAL ), a leading provider of advanced ... its pioneering work in,developing advanced visualization and analysis software. ... and has continually advanced,the field of advanced visualization through ... "I have been ...
... Hearing to coincide with the 19th anniversary of the adoption of ... , ARLINGTON, Va., Nov. 19 ... Ratification of the Convention on the Rights of the Child (CRC), ... host a Senate Staff Briefing on Children,s Health Issues and The ...
Cached Medicine News:Health News:Care Improvement Plus Achieves Top Scores for First SNP Evaluation Measures 2Health News:Bradmer to present poster on progression free survival and overall survival data from Neuradiab(TM) Phase II trials at Society for Neuro-Oncology Meeting 2Health News:Bradmer to present poster on progression free survival and overall survival data from Neuradiab(TM) Phase II trials at Society for Neuro-Oncology Meeting 3Health News:Bradmer to present poster on progression free survival and overall survival data from Neuradiab(TM) Phase II trials at Society for Neuro-Oncology Meeting 4Health News: OneMedPlace announces "OneMedForum 2009" finance conference for emerging medtech companies : Second annual event to be held January 13-14, 2009, in San Francisco 2Health News:InVitria to Launch "BE FREE" Promotion at TERMIS '08 in San Diego 2Health News:Vital Images Celebrates Its 20th Anniversary 2Health News:Vital Images Celebrates Its 20th Anniversary 3Health News:Linda Spears, CWLA Vice President of Policy Will Speak at Senate Briefing 2
... Perfect Pupil Injectable was designed to provide the ... the risk of surgical complications during cataract and ... device for small and medium sized pupils which ... protects the iris sphincter during surgery, and allows ...
... Kojair Laminar Flow Unit is a flexible, ... air conditioning to operating theaters since 1983. A ... Our diverse and extensive experience from all the ... of the product , ,Kojair Tech Oy is ...
Provides stable positioning of the knee during surgery....
BRAT 2 Autologous Blood Recovery System gives performance, speed, versatility, and quality processing. , ,The BRAT 2 is now available with on-board Vacuum, programmability, plasma sequestration, Data...
Medicine Products: